Cargando…
Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials
PURPOSE: To analyze long-term results of two multicenter prospective single-arm trials (ARO-2010-01 and ARO-2013-04) investigating adjuvant hypofractionated radiotherapy (HF) with simultaneous integrated boost (SIB) after breast-conserving surgery (BCS). METHODS: Eligible patients had histopathologi...
Autores principales: | Pfaffendorf, Charlotte, Vonthein, Reinhard, Krockenberger-Ziegler, Katja, Dellas, Kathrin, Schreiber, Andreas, Uhlemann, Dorit, Dinges, Stefan, Würschmidt, Florian, Andreas, Peter, Weinstrauch, Evelyn, Eilf, Kirsten, Rades, Dirk, Höller, Ulrike, Combs, Stephanie E., Kazmierczak, Renata, Fehlauer, Fabian, Schreck, Ulrike, Zimmer, Jörg, Dunst, Jürgen, Krug, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190051/ https://www.ncbi.nlm.nih.gov/pubmed/35691249 http://dx.doi.org/10.1016/j.breast.2022.05.008 |
Ejemplares similares
-
Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial
por: Krug, David, et al.
Publicado: (2020) -
Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial
por: Krug, David, et al.
Publicado: (2020) -
Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial
por: Jiang, Ping, et al.
Publicado: (2017) -
Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
por: Dellas, Kathrin, et al.
Publicado: (2013) -
The prognostic value of tumor necrosis in patients undergoing stereotactic radiosurgery of brain metastases
por: Martens, Kristina, et al.
Publicado: (2013)